BioSpace News Archive

Business

Align Technology Announces Third Quarter 2019 Financial Results

Q3 revenues up 20.2% year-over-year to a record $607.3 million

October 23, 2019
·
16 min read
Business

TransMedics Announces Change to Time of Third Quarter 2019 Earnings Conference Call on Wednesday, November 6

The corresponding conference call hosted by the TransMedics management team is now set to begin at 8:30 a.m. ET / 5:30 a.m. PT.

October 23, 2019
·
1 min read
Business

LeMaitre Vascular Announces Q3 2019 Financial Results

Sales of $29.1mm, +20% (+13% organic) vs. Q3 2018

October 23, 2019
·
14 min read
Biotech Beach

Amgen Recommends Rejection Of ‘Mini-Tender’ Offer From TRC Capital Corporation

TRC Capital’s unsolicited “mini-tender” offer price of $192.00 per share is approximately 4.38% below the $200.80 per share closing price of Amgen’s common stock on Oct. 11, 2019, the last trading day prior to the commencement of the offer

October 23, 2019
·
7 min read
BioCapital

Vanda Announces New Study Results Showing a High Degree of Inbreeding in Beagle Dogs

Vanda Pharmaceuticals Inc. announced results of a comparative genomics study presented at the 2019 American Society of Human Genetics conference on October 19, 2019, entitled “Using Patterns in Regions of Homozygosity to Evaluate the Use of Dogs as Preclinical Models in Human Drug Development”..

October 23, 2019
·
2 min read
Business

Varian Reports Results for Fourth Quarter and Full Fiscal Year 2019; Appoints New President of Interventional Oncology Solutions and New Chief Financial Officer

Oncology Systems gross orders grew 7% in dollars and 7% in constant currency; North America gross orders grew 10%; 17 Ethos™ orders received in Europe and Australia

October 23, 2019
·
24 min read
Business

Allievex Completes Series A Financing Led by Pappas Capital and Novo Holdings

Newly Formed Clinical-Stage Biotechnology Company to Develop Treatments for Rare Pediatric Neurodegenerative Diseases

October 23, 2019
·
6 min read
Business

Semler to Report Third Quarter and First Nine Months of 2019 Financial Results and Host Conference Call on October 30, 2019

Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 p.m. ET the same day.

October 23, 2019
·
2 min read
Business

BioMarin Announces Third Quarter 2019 Financial Results

The Company Achieved Record Total Revenues of $461.1 million; Increased 18% Year Over Year

October 23, 2019
·
28 min read
Business

Acorda Therapeutics Implements Corporate Restructuring, Provides Third Quarter 2019 Update

Total non-GAAP operating expenses for the full year 2020 expected to be $180 - $190 million

October 23, 2019
·
7 min read